NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
13
RVNC Quote, Financials, Valuation and Earnings
Last price:
$3.08
Seasonality move
:
-2.77%
Day range:
$3.07 - $3.09
52-week range:
$2.30 - $9.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.16x
P/B ratio:
--
Volume:
3.5M
Avg. volume:
3.6M
1-year change:
-59.37%
Market cap:
$323.1M
Revenue:
$234M
EPS (TTM):
-$1.94
RVNC Analysts' Consensus Rating
The 8 analysts providing 12-month price projections for Revance Therapeutics shares anticipate an average target of $7.64, ranging from a low estimate of $3.00 to a high estimate of $25.00. This average target implies a growth of 147.96% compared to the current stock price of $3.08.
Consensus Price Target
$7.64
Highest Price Target
$25.00
Lowest Price Target
$3.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 4 | 1 | 1 |
| Hold | 4 | 8 | 7 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Hold | Hold |
RVNC Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 2.5% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 3% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.85% over the past day.
